A Win For Cyclacel Pharmaceuticals, Inc.
Fri, Oct 13, 2023 at 07:22 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) soared at $0.62, representing a gain of 38.4%. On Fri, Oct 13, 2023, CYCC:NASDAQ touched a New 2-Week High of $0.62. From Fri, Sep 29, 2023, the stock recorded 70.00% Up Days and 45.45% Green Days
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Sigma Additive Solutions (SASI:NASDAQ), 139.52%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 90.31%
- P&F Industries, Inc. (PFIN:NASDAQ), 86.58%
- Vinco Ventures Inc. (BBIG:NASDAQ), 60%
- ParaZero Technologies Ltd. (PRZO:NASDAQ), 54.93%
- MicroAlgo Inc. (MLGO:NASDAQ), 47.35%
- Agape ATP Corporation (ATPC:NASDAQ), 45.45%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 38.36%
- The NFT Gaming Company Inc. (NFTG:NASDAQ), 38.33%
- Eightco Holdings Inc Com (New) (OCTO:NASDAQ), 32.88%